By: Scott A. Edmonds, Christine Klimanskis
Key takeaways: Patients should be counseled about ARBs, ACE inhibitors, NSAIDs and proton pump inhibitors.
Christine Klimanskis is a Copy Chief at Healio. She specializes in medicine and healthcare, focusing on topics such as surgical procedures, medical technology innovations, and patient care. Klimanskis has been featured in the World Wealth Journal and Healio, showcasing her expertise in medical journalism.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Christine Klimanskis' articles predominantly focus on ophthalmology, eye diseases, medical technology, and surgical procedures. Her coverage frequently cites data and incorporates expert commentary.
Given her emphasis on scientific research and healthcare advancements in ophthalmology, Christine may be interested in pitches from professionals who can provide substantive insights into new diagnostic tools or emerging treatments for eye diseases. Sources with expertise in ophthalmic research or clinical practice management could offer valuable contributions to her work.
As she does not have a specific geographic focus, experts from various regions who are at the forefront of innovative developments in ophthalmology and related fields may find success when reaching out to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .